tiprankstipranks
KYORIN Pharmaceutical Co.,Ltd. (JP:4569)
:4569
Japanese Market
4569
KYORIN Pharmaceutical Co.,Ltd.
RESEARCH TOOLSreports

KYORIN Pharmaceutical Co.,Ltd. (4569) Financial Statements

Compare
3 Followers

KYORIN Pharmaceutical Co.,Ltd. Financial Overview

KYORIN Pharmaceutical Co.,Ltd.'s market cap is currently ¥88.49B. The company's EPS TTM is ¥45.7; its P/E ratio is 8.41; and it has a dividend yield of 3.36%. KYORIN Pharmaceutical Co.,Ltd. is scheduled to report earnings on February 4, 2026, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue¥ 130.09B¥ 119.53B¥ 113.27B¥ 105.53B¥ 102.90B
Gross Profit¥ 59.51B¥ 51.62B¥ 50.16B¥ 49.44B¥ 51.62B
Operating Income¥ 12.55B¥ 6.23B¥ 5.12B¥ 5.00B¥ 5.78B
EBITDA¥ 17.15B¥ 10.52B¥ 8.96B¥ 8.72B¥ 9.34B
Net Income¥ 9.09B¥ 5.47B¥ 4.72B¥ 3.93B¥ 6.13B
Balance Sheet
Cash & Short-Term Investments¥ 16.51B¥ 13.98B¥ 19.39B¥ 27.49B¥ 30.84B
Total Assets¥ 193.62B¥ 177.63B¥ 176.04B¥ 171.92B¥ 167.13B
Total Debt¥ 28.44B¥ 20.95B¥ 21.28B¥ 21.62B¥ 21.88B
Net Debt¥ 13.42B¥ 7.06B¥ 1.88B¥ -5.37B¥ -5.56B
Total Liabilities¥ 57.33B¥ 46.89B¥ 50.58B¥ 47.41B¥ 42.46B
Stockholders' Equity¥ 136.28B¥ 130.74B¥ 125.46B¥ 124.51B¥ 124.66B
Cash Flow
Free Cash Flow¥ -2.19B¥ -4.23B¥ -4.32B¥ 3.90B¥ 1.12B
Operating Cash Flow¥ 3.51B¥ 1.55B¥ 2.01B¥ 6.35B¥ 5.19B
Investing Cash Flow¥ -6.32B¥ -3.19B¥ -6.28B¥ -2.56B¥ -4.26B
Financing Cash Flow¥ 3.95B¥ -3.35B¥ -3.36B¥ -4.11B¥ -4.92B
Currency in JPY

KYORIN Pharmaceutical Co.,Ltd. Earnings and Revenue History

Income Statement >

KYORIN Pharmaceutical Co.,Ltd. Debt to Assets

Balance Sheet >

KYORIN Pharmaceutical Co.,Ltd. Cash Flow

Cash Flow >

KYORIN Pharmaceutical Co.,Ltd. Forecast EPS vs Actual EPS

Earnings >